Cite
Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells.
MLA
Zhao, Kai, et al. “Oroxylin A Promotes PTEN-Mediated Negative Regulation of MDM2 Transcription via SIRT3-Mediated Deacetylation to Stabilize P53 and Inhibit Glycolysis in Wt-P53 Cancer Cells.” Journal of Hematology & Oncology, vol. 8, no. 1, Apr. 2015, pp. 1–18. EBSCOhost, https://doi.org/10.1186/s13045-015-0137-1.
APA
Zhao, K., Zhou, Y., Qiao, C., Ni, T., Li, Z., Wang, X., Guo, Q., Lu, N., & Wei, L. (2015). Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells. Journal of Hematology & Oncology, 8(1), 1–18. https://doi.org/10.1186/s13045-015-0137-1
Chicago
Zhao, Kai, Yuxin Zhou, Chen Qiao, Ting Ni, Zhiyu Li, Xiaotang Wang, Qinglong Guo, Na Lu, and Libin Wei. 2015. “Oroxylin A Promotes PTEN-Mediated Negative Regulation of MDM2 Transcription via SIRT3-Mediated Deacetylation to Stabilize P53 and Inhibit Glycolysis in Wt-P53 Cancer Cells.” Journal of Hematology & Oncology 8 (1): 1–18. doi:10.1186/s13045-015-0137-1.